IPHARMA will take a part in the "Clinical trials in Russia" Adam Smith Forum
On November 8-10th, IPHARMA will take a part in the "Clinical trials in Russia" Adam Smith Forum which is the main event of the year in the clinical trials field.
As in previous years, IPHARMA has become a sponsor of this event and will report on current issues in the industry.
This year’s program will be quite rich and will consist of 3 days of seminars, discussions and plenary sessions. More than 150 participants and 40 experts and professionals in biopharmaceutical industry will present their reports at the Forum.
The participants could learn more about our company and services at IPHARMA’s stand.
On November 10th, IPHARMA staff will present their reports:
- At 09:40 AM: The report of IPHARMA Chief Operating Officer Natalia Vostokova "Effective clinical trial design. How to make a clinical trial more effective?"
The effective design is a key factor of a clinical trial success. A thoughtful selection of endpoints, comparative drugs, statistical hypothesis and other aspects provides the increase of study results forecastability, which is especially important in conditions of the limited funding, short timeframes and high competition.
- At 12:15 PM: The report of IPHARMA Medical Director Julia Trachtenberg "Medical monitoring as a basis for pharmacovigilance system in the clinical trials".
Organization of pharmacovigilance system in accordance with the current regulatory requirements. The accurate collection and competent analysis of data as well as the safety monitoring help to minimize the risks associated with the drug administration.